Assistant Professor of Clinical Urology; Urologist
We understand infertility issues can be devastating for a couple and you may have many questions regarding your future ability to have a family. Our team is dedicated to providing the compassionate care, support, and information you need to better understand your condition and to make decisions about your treatment options.
Yale Urology offers a multidisciplinary, comprehensive approach to treating male infertility issues. We are committed to offering our patients the most advanced diagnostic technologies and treatment strategies available. Our team is at the forefront of research in men’s health issues, and our surgeons continually integrate the latest in science-based medicine and innovative approaches into their practice to offer patients the safest and most effective treatments.
Yale Urology is dedicated to helping men who are experiencing infertility using the most advanced techniques available. We conduct sophisticated computer-assisted semen analyses, antisperm antibody testing, and sperm morphometry/morphology evaluations. We also offer a sperm migration test, which provides an assessment of the progression efficiency of sperm available for fertilization and tests the maintenance of sperm motility. Yale Urology surgeons are dedicated to using the most minimally invasive treatments available, providing faster recovery and superior outcomes for patients.
Male Factor Infertility
Infertility is defined as the inability to achieve a pregnancy after 12 months of unprotected intercourse. Approximately 40-50% of the time, this is related to a male factor problem, which can mean one or a combination of low sperm concentration, poor sperm motility, or abnormal morphology. An initial evaluation should include a semen analysis, and if this is found to be abnormal, a referral to a reproductive urologist is recommended. The first step in evaluation involves a review of the patient's history and a physical examination. The comprehensive urologic evaluation is important because it can possibly identify significant and potentially treatable conditions that may be impacting fertility.